S&P 500   3,012.67 (+0.20%)
DOW   26,917.04 (+0.33%)
QQQ   193.16 (-0.12%)
AAPL   241.43 (+0.38%)
FB   184.17 (-2.95%)
MSFT   137.86 (-0.41%)
GOOGL   1,243.26 (-0.08%)
AMZN   1,774.13 (-0.65%)
CGC   20.86 (+2.51%)
NVDA   197.20 (+0.61%)
MU   45.30 (+0.18%)
BABA   170.02 (-2.02%)
AMD   31.82 (-0.66%)
T   38.27 (+0.10%)
F   9.10 (+0.78%)
PRI   126.01 (+0.25%)
NFLX   269.39 (-3.11%)
BAC   31.32 (+0.97%)
GILD   66.22 (+1.55%)
DIS   132.81 (+1.96%)
S&P 500   3,012.67 (+0.20%)
DOW   26,917.04 (+0.33%)
QQQ   193.16 (-0.12%)
AAPL   241.43 (+0.38%)
FB   184.17 (-2.95%)
MSFT   137.86 (-0.41%)
GOOGL   1,243.26 (-0.08%)
AMZN   1,774.13 (-0.65%)
CGC   20.86 (+2.51%)
NVDA   197.20 (+0.61%)
MU   45.30 (+0.18%)
BABA   170.02 (-2.02%)
AMD   31.82 (-0.66%)
T   38.27 (+0.10%)
F   9.10 (+0.78%)
PRI   126.01 (+0.25%)
NFLX   269.39 (-3.11%)
BAC   31.32 (+0.97%)
GILD   66.22 (+1.55%)
DIS   132.81 (+1.96%)
Log in

Penumbra Stock Price, News & Analysis (NYSE:PEN)

$150.45
+2.82 (+1.91 %)
(As of 10/22/2019 12:32 PM ET)
Today's Range
$146.67
Now: $150.45
$150.45
50-Day Range
$131.82
MA: $142.82
$151.26
52-Week Range
$110.84
Now: $150.45
$185.70
Volume11,010 shs
Average Volume483,408 shs
Market Capitalization$5.23 billion
P/E Ratio295.00
Dividend YieldN/A
Beta0.71
Penumbra, Inc designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone510-748-3200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$444.94 million
Cash Flow$0.73 per share
Book Value$12.24 per share

Profitability

Net Income$6.60 million

Miscellaneous

Employees2,200
Market Cap$5.23 billion
Next Earnings Date11/7/2019 (Confirmed)
OptionableOptionable

Receive PEN News and Ratings via Email

Sign-up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter.


Penumbra (NYSE:PEN) Frequently Asked Questions

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

How were Penumbra's earnings last quarter?

Penumbra Inc (NYSE:PEN) issued its earnings results on Tuesday, August, 6th. The company reported $0.27 EPS for the quarter, beating the Zacks' consensus estimate of $0.21 by $0.06. The firm had revenue of $134.20 million for the quarter, compared to analyst estimates of $130.67 million. Penumbra had a return on equity of 6.80% and a net margin of 3.03%. Penumbra's revenue for the quarter was up 22.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.15 earnings per share. View Penumbra's Earnings History.

When is Penumbra's next earnings date?

Penumbra is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Penumbra.

How can I listen to Penumbra's earnings call?

Penumbra will be holding an earnings conference call on Thursday, November 7th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Penumbra issued on next quarter's earnings?

Penumbra issued an update on its FY 2019 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $535-540 million, compared to the consensus revenue estimate of $536.57 million.

What price target have analysts set for PEN?

8 Wall Street analysts have issued 12-month price objectives for Penumbra's shares. Their predictions range from $152.00 to $185.00. On average, they anticipate Penumbra's stock price to reach $170.17 in the next twelve months. This suggests a possible upside of 13.1% from the stock's current price. View Analyst Price Targets for Penumbra.

What is the consensus analysts' recommendation for Penumbra?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Penumbra.

Has Penumbra been receiving favorable news coverage?

Media stories about PEN stock have been trending negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Penumbra earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Penumbra.

Are investors shorting Penumbra?

Penumbra saw a increase in short interest in September. As of September 30th, there was short interest totalling 6,370,000 shares, an increase of 11.6% from the August 30th total of 5,710,000 shares. Based on an average daily volume of 560,200 shares, the short-interest ratio is presently 11.4 days. Currently, 19.9% of the company's stock are short sold. View Penumbra's Current Options Chain.

Who are some of Penumbra's key competitors?

What other stocks do shareholders of Penumbra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), salesforce.com (CRM), Splunk (SPLK), Adobe (ADBE), Intuitive Surgical (ISRG), Paypal (PYPL), Twilio (TWLO) and Tesla (TSLA).

Who are Penumbra's key executives?

Penumbra's management team includes the folowing people:
  • Mr. Adam Elsesser, Co Founder, Chairman, CEO & Pres (Age 57)
  • Dr. Arani Bose, Co-Founder, Chief Innovator and Director (Age 57)
  • Mr. Sridhar N. Kosaraju, CFO and Head of Strategy (Age 41)
  • Ms. Lynn Rothman, Chief Bus. Officer and Exec. VP (Age 58)
  • Mr. Daniel Donen Davis, Chief Commercial Officer (Age 41)

Who are Penumbra's major shareholders?

Penumbra's stock is owned by many different of retail and institutional investors. Top institutional investors include Stephens Investment Management Group LLC (0.88%), KAMES CAPITAL plc (0.06%), Pacer Advisors Inc. (0.03%), Calamos Advisors LLC (0.03%), Virginia Retirement Systems ET AL (0.02%) and State of Alaska Department of Revenue (0.02%). Company insiders that own Penumbra stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Daniel Donen Davis, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Robert D Evans, Sridhar Kosaraju and Thomas Wilder. View Institutional Ownership Trends for Penumbra.

Which major investors are selling Penumbra stock?

PEN stock was sold by a variety of institutional investors in the last quarter, including Calamos Advisors LLC. Company insiders that have sold Penumbra company stock in the last year include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Sridhar Kosaraju and Thomas Wilder. View Insider Buying and Selling for Penumbra.

Which major investors are buying Penumbra stock?

PEN stock was acquired by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., Stephens Investment Management Group LLC, KAMES CAPITAL plc, Crossmark Global Holdings Inc., Virginia Retirement Systems ET AL, State of Alaska Department of Revenue, Envestnet Asset Management Inc. and Campbell & CO Investment Adviser LLC. View Insider Buying and Selling for Penumbra.

How do I buy shares of Penumbra?

Shares of PEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Penumbra's stock price today?

One share of PEN stock can currently be purchased for approximately $150.45.

How big of a company is Penumbra?

Penumbra has a market capitalization of $5.23 billion and generates $444.94 million in revenue each year. The company earns $6.60 million in net income (profit) each year or $0.51 on an earnings per share basis. Penumbra employs 2,200 workers across the globe.View Additional Information About Penumbra.

What is Penumbra's official website?

The official website for Penumbra is http://www.penumbrainc.com/.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The company can be reached via phone at 510-748-3200 or via email at [email protected]


MarketBeat Community Rating for Penumbra (NYSE PEN)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  526 (Vote Outperform)
Underperform Votes:  192 (Vote Underperform)
Total Votes:  718
MarketBeat's community ratings are surveys of what our community members think about Penumbra and other stocks. Vote "Outperform" if you believe PEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel